(19)
(11) EP 0 701 401 A1

(12)

(43) Date of publication:
20.03.1996 Bulletin 1996/12

(21) Application number: 94914075.0

(22) Date of filing: 07.04.1994
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
C07H 17/ 00( . )
C12N 5/ 10( . )
C12N 15/ 861( . )
A61K 48/ 00( . )
A61K 38/ 00( . )
C07K 14/ 785( . )
C12N 7/ 00( . )
C12P 21/ 02( . )
C12R 1/ 91( . )
(86) International application number:
PCT/US1994/003831
(87) International publication number:
WO 1994/023582 (27.10.1994 Gazette 1994/24)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 08.04.1993 US 19930044406

(71) Applicants:
  • GENETIC THERAPY, INC.
    Gaithersburg, MD 20878 (US)
  • UNIVERSITY OF CINCINNATI CHILDREN'S HOSPITAL
    Cincinnati, OH 45229-2899 (US)

(72) Inventors:
  • TRAPNELL, Bruce
    Kensington, MD 20895 (US)
  • WHITSETT, Jeffrey
    Cincinnati, OH 45230 (US)

(74) Representative: LOUIS, PÖHLAU, LOHRENTZ & SEGETH 
Postfach 3055
D-90014 Nürnberg
D-90014 Nürnberg (DE)

   


(54) ADENOVIRAL VECTORS INCLUDING DNA ENCODING LUNG SURFACTANT PROTEIN